Get started
THE BIOMEDTHE BIOMEDTHE BIOMED

THE BIOMED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

214610 chart


Full chart

Key stats


Market capitalization
‪35.63 B‬ KRW
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−6,890 KRW
Net income (FY)
‪−30.85 B‬ KRW
Revenue (FY)
‪4.64 B‬ KRW
Shares float
‪5.15 M‬
Beta (1Y)
0.71

Employees


Employees (FY)
52
Change (1Y)
−41 −44.09%
Revenue / Employee (1Y)
‪89.23 M‬ KRW
Net income / Employee (1Y)
‪−539.67 M‬ KRW

About THE BIOMED


Sector
Health Technology
Industry
Medical Specialties
CEO
Min-Yeong Jeong
Website
micobiomed.com
Headquarters
Seongnam-si
Founded
2009
ISIN
KR7214610008
FIGI
BBG009DXNQ82
THE BioMed Co. Ltd. engages in the development and commercialization of molecular diagnostic equipment and kits based on LabChip technology. Its product includes compact extraction equipment, genes extraction reagent, saliva sample collection kit, molecular diagnostic reagents, microfluidic lab chip, combination meters and strips, hemoglobin meters and strips, blood glucose meters and strips, microplate, immunodiagnostic reader, antibody diagnostic and antigen kit, neutralizing antibody diagnostic kit, and ELISA diagnostic kit. The company was founded on March 6, 2009 and is headquartered in Seongnam-si, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

214610 news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 214610.

Frequently Asked Questions


The current price of 214610 is 6,930 KRW — it has decreased by −18.18% in the past 24 hours. Watch THE BIOMED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange THE BIOMED stocks are traded under the ticker 214610.
214610 stock has risen by 50.82% compared to the previous week, the month change is a 46.51% rise, over the last year THE BIOMED has showed a −49.42% decrease.
214610 reached its all-time high on Jun 24, 2022 with the price of 146,130 KRW, and its all-time low was 4,360 KRW and was reached on May 9, 2025. View more price dynamics on 214610 chart.
See other stocks reaching their highest and lowest prices.
214610 stock is 24.74% volatile and has beta coefficient of 0.71. Track THE BIOMED stock price on the chart and check out the list of the most volatile stocks — is THE BIOMED there?
Today THE BIOMED has the market capitalization of ‪35.69 B‬, it has decreased by −10.17% over the last week.
Yes, you can track THE BIOMED financials in yearly and quarterly reports right on TradingView.
214610 net income for the last quarter is ‪−2.68 B‬ KRW, while the quarter before that showed ‪−6.13 B‬ KRW of net income which accounts for 56.33% change. Track more THE BIOMED financial stats to get the full picture.
No, 214610 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 24, 2025, the company has 52 employees. See our rating of the largest employees — is THE BIOMED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THE BIOMED EBITDA is ‪−24.16 B‬ KRW, and current EBITDA margin is −434.73%. See more stats in THE BIOMED financial statements.
Like other stocks, 214610 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THE BIOMED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THE BIOMED technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THE BIOMED stock shows the sell signal. See more of THE BIOMED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.